# SHEUR
> **ANDA217650** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARM · Approved 2025-09-22
## Drug
- **FDA Application Number:** ANDA217650
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SHEUR
- **Generic name:** Elagolix, Estradiol And Norethindrone Acetate And Elagolix
- **Active ingredients:** ELAGOLIX, ESTRADIOL AND NORETHINDRONE ACETATE AND ELAGOLIX
- **Dosage form:** CAPSULE
- **Route:** —
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARM
- **First approval:** 2025-09-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217650)
---
*MORVS · CC0 1.0*